Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mulmin Syrup
- Development stage
- Unknown
- Lead developer
- Juggat Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mulmin Syrup is a pediatric multivitamin and multimineral supplement developed and marketed by Juggat Pharma, a division of Jagdale Industries. It is formulated to address nutritional deficiencies, prevent 'hidden hunger', and support overall growth, appetite, cognitive development, and immune function in infants and children. The syrup contains a combination of essential vitamins and minerals, including Vitamin A, Vitamin D3, Vitamin B-complex (B1, B2, B3, B5, B6, B12), and Zinc. It is administered orally and is widely used as a daily dietary supplement.
- Brand names
- MulminMulmin Syrup
02
Targets
RAR (Retinoic acid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Mulmin Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mulmin Syrup.